187 related articles for article (PubMed ID: 8931778)
1. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
Rizzardi GP; Barcellini W; Tambussi G; Lillo F; Malnati M; Perrin L; Lazzarin A
AIDS; 1996 Nov; 10(13):F45-50. PubMed ID: 8931778
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy.
Rizzardi GP; Tambussi G; Barcellini W; Capiluppi B; Clerici E; Maestra LL; Lillo F; Pantaleo G; Lazzarin A
J Biol Regul Homeost Agents; 1997; 11(1-2):43-9. PubMed ID: 9418161
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of sTNFR p75 and IL-8 in patients with HIV-1 infection.
Hober D; Benyoucef S; Delannoy AS; De Groote D; Ajana F; Mouton Y; Wattré P
Immunol Lett; 1996 Aug; 52(1):57-60. PubMed ID: 8877420
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
5. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea.
Nokta M; Rossero R; Loesch K; Pollard RB
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1633-8. PubMed ID: 9430255
[TBL] [Abstract][Full Text] [Related]
9. Soluble tumor necrosis factor receptor type II (sTNFRII) in HIV-infected patients: relationship with the plasma level of HIV-1 RNA.
Hober D; Benyoucef S; Bocket L; Chieux V; Lion G; Mouton Y; De Groote D; Wattré P
Immunol Lett; 1999 Apr; 67(2):91-4. PubMed ID: 10232388
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
[TBL] [Abstract][Full Text] [Related]
11. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
Sulkowski MS; Chaisson RE; Karp CL; Moore RD; Margolick JB; Quinn TC
J Infect Dis; 1998 Dec; 178(6):1642-8. PubMed ID: 9815216
[TBL] [Abstract][Full Text] [Related]
12. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
[TBL] [Abstract][Full Text] [Related]
13. High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients.
Hober D; Benyoucef S; Delannoy AS; de Groote D; Ajana F; Mouton Y; Wattré P
Infection; 1996; 24(3):213-7. PubMed ID: 8811358
[TBL] [Abstract][Full Text] [Related]
14. 'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
Lederman MM; Kalish LA; Asmuth D; Fiebig E; Mileno M; Busch MP
AIDS; 2000 May; 14(8):951-8. PubMed ID: 10853976
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of soluble tumour necrosis factor receptor-I (P55) and decreased IgG1 reactivities in HIV-1 patients with cytomegalovirus disease.
Jakobsen PH; Dodt KK; Meyer CN; Katzenstein T; Gerstoft J; Skinhøj P
Scand J Immunol; 1998 Jun; 47(6):591-5. PubMed ID: 9652828
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
Infection; 1996; 24(4):301-8. PubMed ID: 8875282
[TBL] [Abstract][Full Text] [Related]
17. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS.
Pizzolo G; Vinante F; Morosato L; Nadali G; Chilosi M; Gandini G; Sinicco A; Raiteri R; Semenzato G; Stein H
AIDS; 1994 Jun; 8(6):741-5. PubMed ID: 8086130
[TBL] [Abstract][Full Text] [Related]
18. High blood soluble receptor p80 for tumour necrosis factor-alpha is associated with erythropoietin resistance in haemodialysis patients.
Kato A; Odamaki M; Takita T; Furuhashi M; Maruyama Y; Hishida A
Nephrol Dial Transplant; 2001 Sep; 16(9):1838-44. PubMed ID: 11522867
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.
Savès M; Morlat P; Chêne G; Peuchant E; Pellegrin I; Bonnet F; Bernard N; Lacoste D; Salamon R; Beylot J
Clin Immunol; 2001 Jun; 99(3):347-52. PubMed ID: 11358430
[TBL] [Abstract][Full Text] [Related]
20. [Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis].
He S; Huang H
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):526-8. PubMed ID: 10436957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
